These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 11207038

  • 1. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S, Tornesello A, Diociaiuti L, Pession A, Prete A, Rufini V, Troncone L, Mastrangelo R.
    Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
    [Abstract] [Full Text] [Related]

  • 2. Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
    Mastrangelo S, Rufini V, Ruggiero A, Di Giannatale A, Riccardi R.
    Pediatr Blood Cancer; 2011 Jul 01; 56(7):1032-40. PubMed ID: 21344615
    [Abstract] [Full Text] [Related]

  • 3. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L, Rufini V, Luzi S, Mastrangelo R, Riccardi R.
    Q J Nucl Med; 1995 Dec 01; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [Abstract] [Full Text] [Related]

  • 4. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S, Tornesello A, Diociaiuti L, Riccardi R, Rufini V, Troncone L.
    Q J Nucl Med; 1995 Dec 01; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [Abstract] [Full Text] [Related]

  • 5. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
    Valteau-Couanet D, Michon J, Boneu A, Rodary C, Perel Y, Bergeron C, Rubie H, Coze C, Plantaz D, Bernard F, Chastagner P, Bouzy J, Hartmann O.
    J Clin Oncol; 2005 Jan 20; 23(3):532-40. PubMed ID: 15659499
    [Abstract] [Full Text] [Related]

  • 6. [131I]MIBG as a first line treatment in advanced neuroblastoma.
    Hoefnagel CA, De Kraker J, Valdés Olmos RA, Voûte PA.
    Q J Nucl Med; 1995 Dec 20; 39(4 Suppl 1):61-4. PubMed ID: 9002752
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
    Howard JP, Maris JM, Kersun LS, Huberty JP, Cheng SC, Hawkins RA, Matthay KK.
    Pediatr Blood Cancer; 2005 Mar 20; 44(3):232-9. PubMed ID: 15490487
    [Abstract] [Full Text] [Related]

  • 10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 20; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma.
    Johnson K, McGlynn B, Saggio J, Baniewicz D, Zhuang H, Maris JM, Mosse YP.
    Pediatr Blood Cancer; 2011 Dec 15; 57(7):1124-9. PubMed ID: 21495159
    [Abstract] [Full Text] [Related]

  • 12. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.
    Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK.
    J Clin Oncol; 2004 Dec 15; 22(24):4888-92. PubMed ID: 15611504
    [Abstract] [Full Text] [Related]

  • 13. Combined use of chemotherapy and 131I-metaiodobenzylguanidine in the treatment of advanced-stage neuroblastoma.
    Sari O, Uğur O, Emir S, Akyüz C.
    Turk J Pediatr; 2001 Dec 15; 43(1):29-33. PubMed ID: 11297155
    [Abstract] [Full Text] [Related]

  • 14. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K, Fukuda M, Miyajima Y, Matsumoto K, Kondo M, Inaba J, Miyashita Y.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):203-4. PubMed ID: 11464885
    [Abstract] [Full Text] [Related]

  • 15. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
    Schmidt M, Simon T, Hero B, Eschner W, Dietlein M, Sudbrock F, Bongartz R, Berthold F, Schicha H.
    Nuklearmedizin; 2006 Jan 15; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
    [Abstract] [Full Text] [Related]

  • 16. Neuroblastoma.
    Meir HM, Balawi I, Nayel H, Yousef MK, Badawood S, Al-Mobarak M.
    Saudi Med J; 2001 Aug 15; 22(8):674-80. PubMed ID: 11573111
    [Abstract] [Full Text] [Related]

  • 17. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK, Kushner BH, LaQuaglia M, Kramer K, Gollamudi S, Heller G, Gerald W, Yeh S, Finn R, Larson SM, Wuest D, Byrnes M, Dantis E, Mora J, Cheung IY, Rosenfield N, Abramson S, O'Reilly RJ.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):227-30. PubMed ID: 11464891
    [Abstract] [Full Text] [Related]

  • 18. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
    Matthay KK, Yanik G, Messina J, Quach A, Huberty J, Cheng SC, Veatch J, Goldsby R, Brophy P, Kersun LS, Hawkins RA, Maris JM.
    J Clin Oncol; 2007 Mar 20; 25(9):1054-60. PubMed ID: 17369569
    [Abstract] [Full Text] [Related]

  • 19. Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
    Matthay KK, Tan JC, Villablanca JG, Yanik GA, Veatch J, Franc B, Twomey E, Horn B, Reynolds CP, Groshen S, Seeger RC, Maris JM.
    J Clin Oncol; 2006 Jan 20; 24(3):500-6. PubMed ID: 16421427
    [Abstract] [Full Text] [Related]

  • 20. [131(I)-meta-iodobenzylguanidine treatment of 32 children with therapy-refractory neuroblastoma].
    Berthold F, Feine U, Fischer M, Gerein V, Klingebiel T, Maul FD, Waters W, Wehinger H, Treuner J.
    Klin Padiatr; 1988 Jan 20; 200(3):226-9. PubMed ID: 3062260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.